Patent · US Active

Molecules specifically binding pancreatic beta cells biomarkers

US8981053B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignees

Universite De Mons · BE
UNIVERSITÉ LIBRE DE BRUXELLES · BE
EUROGENTEC S.A. · FR

Inventors

Robert Muller · Potsdam, DE
Decio L. Eizirik · Dilbeek, BE
Corine Sermeus · Enghien, BE
Sophie Laurent · Nantes, FR
Carmen Burtea · Mons, BE
Marie-Claire Beckers · Beyne-Heusay, BE
Daisy Flamez · Lennik, BE

Key dates

Filing date	Jun 22, 2012
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Jun 22, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/56966
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a synthetic peptide molecule that specifically binds an FXYD2-gamma isoform of pancreatic beta cells, said synthetic peptide molecule has 25 amino acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.